HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors.

Abstract
The neurotransmitter serotonin (5-hydroxytryptamine) is a well-established modulator of energy balance. Both pharmacological and genetic evidence implicate the serotonin 2C receptor (5-HT(2C)R) as a critical receptor mediator of serotonin's effects on ingestive behavior. Here we characterized the effect of the novel and selective 5-HT(2C)R agonist BVT.X on energy balance in obese and lean mice and report that BVT.X significantly reduces acute food intake without altering locomotor activity or oxygen consumption. In an effort to elucidate the mechanism of this effect, we examined the chemical phenotype of 5-HT(2C)R-expressing neurons in a critical brain region affecting feeding behavior, the arcuate nucleus of the hypothalamus. We show that 5-HT(2C)Rs are coexpressed with neurons containing proopiomelanocortin, known to potently affect appetite, in the arcuate nucleus of the hypothalamus of the mouse. We then demonstrate that prolonged infusion with BVT.X in obese mice significantly increases Pomc mRNA and reduces body weight, percent body fat, and initial food intake. To evaluate the functional importance of melanocortin circuitry in the effect of BVT.X on ingestive behavior, we assessed mice with disrupted melanocortin pathways. We report that mice lacking the melanocortin 4 receptor are not responsive to BVT.X-induced hypophagia, demonstrating that melanocortins acting on melanocortin 4 receptor are a requisite downstream pathway for 5-HT(2C)R agonists to exert effects on food intake. The data presented here not only indicate that the novel 5-HT(2C)R agonist BVT.X warrants further investigation as a treatment for obesity but also elucidate specific neuronal pathways potently affecting energy balance through which 5-HT(2C)R agonists regulate ingestive behavior.
AuthorsDaniel D Lam, Magdalena J Przydzial, Simon H Ridley, Giles S H Yeo, Justin J Rochford, Stephen O'Rahilly, Lora K Heisler
JournalEndocrinology (Endocrinology) Vol. 149 Issue 3 Pg. 1323-8 (Mar 2008) ISSN: 0013-7227 [Print] United States
PMID18039773 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Appetite Depressants
  • RNA, Messenger
  • Receptor, Melanocortin, Type 4
  • Receptor, Serotonin, 5-HT2C
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin
  • Pro-Opiomelanocortin
Topics
  • Adipose Tissue (drug effects, metabolism)
  • Animals
  • Appetite Depressants (pharmacology)
  • Appetite Regulation (drug effects, physiology)
  • Disease Models, Animal
  • Eating (drug effects, physiology)
  • Energy Metabolism (drug effects, physiology)
  • Feeding and Eating Disorders (etiology, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Obese
  • Motor Activity (drug effects, physiology)
  • Oxygen Consumption (drug effects, physiology)
  • Pro-Opiomelanocortin (metabolism)
  • RNA, Messenger (metabolism)
  • Receptor, Melanocortin, Type 4 (genetics, metabolism)
  • Receptor, Serotonin, 5-HT2C (metabolism)
  • Serotonin (metabolism)
  • Serotonin 5-HT2 Receptor Agonists

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: